A citation-based method for searching scientific literature

Alan Menter, Gerald G Krueger, So Yeon Paek, Dario Kivelevitch, Iannis E Adamopoulos, Richard G Langley. Dermatol Ther (Heidelb) 2021
Times Cited: 9







List of co-cited articles
39 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications.
Esther von Stebut, Wolf-Henning Boehncke, Kamran Ghoreschi, Tommaso Gori, Ziya Kaya, Diamant Thaci, Andreas Schäffler. Front Immunol 2020
74
33

Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation.
Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu, Alastair D G Lawson, Ash Maroof, Ruth Oliver, Serghei Popa, Foteini Strimenopoulou,[...]. Ann Rheum Dis 2018
120
22

IL-25 (IL-17E) in epithelial immunology and pathophysiology.
Julia Borowczyk, Maria Shutova, Nicolo Costantino Brembilla, Wolf-Henning Boehncke. J Allergy Clin Immunol 2021
38
22

The IL-17 Family of Cytokines in Health and Disease.
Mandy J McGeachy, Daniel J Cua, Sarah L Gaffen. Immunity 2019
451
22

Ixekizumab for the treatment of psoriasis: up-to-date.
Sarah Craig, Richard B Warren. Expert Opin Biol Ther 2020
20
22

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.
B Oppmann, R Lesley, B Blom, J C Timans, Y Xu, B Hunte, F Vega, N Yu, J Wang, K Singh,[...]. Immunity 2000
22

The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond.
Nicolo Costantino Brembilla, Luisa Senra, Wolf-Henning Boehncke. Front Immunol 2018
200
22


Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial.
Kristian Reich, Kim A Papp, Andrew Blauvelt, Richard G Langley, April Armstrong, Richard B Warren, Kenneth B Gordon, Joseph F Merola, Yukari Okubo, Cynthia Madden,[...]. Lancet 2021
55
22


Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis.
S L Gottlieb, P Gilleaudeau, R Johnson, L Estes, T G Woodworth, A B Gottlieb, J G Krueger. Nat Med 1995
484
22

Bimekizumab versus Secukinumab in Plaque Psoriasis.
Kristian Reich, Richard B Warren, Mark Lebwohl, Melinda Gooderham, Bruce Strober, Richard G Langley, Carle Paul, Dirk De Cuyper, Veerle Vanvoorden, Cynthia Madden,[...]. N Engl J Med 2021
47
22

IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice.
Isaac T W Harley, Traci E Stankiewicz, Daniel A Giles, Samir Softic, Leah M Flick, Monica Cappelletti, Rachel Sheridan, Stavra A Xanthakos, Kris A Steinbrecher, R Balfour Sartor,[...]. Hepatology 2014
162
22

Interleukin-17 family members and inflammation.
Jay K Kolls, Anders Lindén. Immunity 2004
22

Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks.
Esther von Stebut, Kristian Reich, Diamant Thaçi, Wolfgang Koenig, Andreas Pinter, Andreas Körber, Tienush Rassaf, Ari Waisman, Venkatesh Mani, Denise Yates,[...]. J Invest Dermatol 2019
101
22

Secukinumab in plaque psoriasis--results of two phase 3 trials.
Richard G Langley, Boni E Elewski, Mark Lebwohl, Kristian Reich, Christopher E M Griffiths, Kim Papp, Lluís Puig, Hidemi Nakagawa, Lynda Spelman, Bárður Sigurgeirsson,[...]. N Engl J Med 2014
22

Psoriasis Pathogenesis and Treatment.
Adriana Rendon, Knut Schäkel. Int J Mol Sci 2019
438
22

Bimekizumab versus Adalimumab in Plaque Psoriasis.
Richard B Warren, Andrew Blauvelt, Jerry Bagel, Kim A Papp, Paul Yamauchi, April Armstrong, Richard G Langley, Veerle Vanvoorden, Dirk De Cuyper, Christopher Cioffi,[...]. N Engl J Med 2021
37
22

Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.
Susanne Karbach, Andrew L Croxford, Matthias Oelze, Rebecca Schüler, Daniel Minwegen, Joanna Wegner, Lija Koukes, Nir Yogev, Alexei Nikolaev, Sonja Reißig,[...]. Arterioscler Thromb Vasc Biol 2014
148
22

Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
Laura Mercurio, Cristina M Failla, Lorena Capriotti, Claudia Scarponi, Francesco Facchiano, Martina Morelli, Stefania Rossi, Gianluca Pagnanelli, Cristina Albanesi, Andrea Cavani,[...]. PLoS One 2020
20
22


Psoriasis.
Wolf-Henning Boehncke, Michael P Schön. Lancet 2015
22

Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
Leslie van der Fits, Sabine Mourits, Jane S A Voerman, Marius Kant, Louis Boon, Jon D Laman, Ferry Cornelissen, Anne-Marie Mus, Edwin Florencia, Errol P Prens,[...]. J Immunol 2009
22

Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses.
Kristin Stelzner, Diana Herbert, Yulia Popkova, Axel Lorz, Jürgen Schiller, Martin Gericke, Nora Klöting, Matthias Blüher, Sandra Franz, Jan C Simon,[...]. Eur J Immunol 2016
47
22

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.
Frank O Nestle, Curdin Conrad, Adrian Tun-Kyi, Bernhard Homey, Michael Gombert, Onur Boyman, Günter Burg, Yong-Jun Liu, Michel Gilliet. J Exp Med 2005
784
22

Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis.
Lazaros I Sakkas, Efterpi Zafiriou, Dimitrios P Bogdanos. Front Pharmacol 2019
42
22


Obesity predisposes to Th17 bias.
Shawn Winer, Geoff Paltser, Yin Chan, Hubert Tsui, Edgar Engleman, Daniel Winer, H-Michael Dosch. Eur J Immunol 2009
262
22

Interferon-α-conditioned human monocytes combine a Th1-orienting attitude with the induction of autologous Th17 responses: role of IL-23 and IL-12.
Stefano M Santini, Caterina Lapenta, Simona Donati, Francesca Spadaro, Filippo Belardelli, Maria Ferrantini. PLoS One 2011
42
22

HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features.
Jóhann E Gudjónsson, Ari Kárason, Arna A Antonsdóttir, E Hjaltey Rúnarsdóttir, Jeffrey R Gulcher, Kári Stefánsson, Helgi Valdimarsson. J Invest Dermatol 2002
146
22

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study.
A Costanzo, L Bianchi, M L Flori, G Malara, L Stingeni, M Bartezaghi, L Carraro, G Castellino. Br J Dermatol 2018
32
22

Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study.
Floranne C Wilson, Murat Icen, Cynthia S Crowson, Marian T McEvoy, Sherine E Gabriel, Hilal Maradit Kremers. Arthritis Rheum 2009
319
22

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial.
Diamant Thaçi, Andrew Blauvelt, Kristian Reich, Tsen-Fang Tsai, Francisco Vanaclocha, Külli Kingo, Michael Ziv, Andreas Pinter, Sophie Hugot, Ruquan You,[...]. J Am Acad Dermatol 2015
369
22

Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F.
Ralph Adams, Asher Maroof, Terry Baker, Alastair D G Lawson, Ruth Oliver, Ross Paveley, Steve Rapecki, Stevan Shaw, Pavan Vajjah, Shauna West,[...]. Front Immunol 2020
38
22


Psoriasis.
Jacqueline E Greb, Ari M Goldminz, James T Elder, Mark G Lebwohl, Dafna D Gladman, Jashin J Wu, Nehal N Mehta, Andrew Y Finlay, Alice B Gottlieb. Nat Rev Dis Primers 2016
376
22

Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial.
Kenneth B Gordon, Peter Foley, James G Krueger, Andreas Pinter, Kristian Reich, Ronald Vender, Veerle Vanvoorden, Cynthia Madden, Katy White, Christopher Cioffi,[...]. Lancet 2021
53
22

Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent.
Robert Bissonnette, Linda Stein Gold, David S Rubenstein, Anna M Tallman, April Armstrong. J Am Acad Dermatol 2021
30
22

Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial.
Kim A Papp, Cathy Reid, Peter Foley, Rod Sinclair, David H Salinger, Gary Williams, Hua Dong, James G Krueger, Chris B Russell, David A Martin. J Invest Dermatol 2012
109
11

First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasis.
Sophie Glatt, Eric Helmer, Birgit Haier, Foteini Strimenopoulou, Graham Price, Pavan Vajjah, Olivier A Harari, John Lambert, Stevan Shaw. Br J Clin Pharmacol 2017
72
11


Impact of Psoriasis on Mortality Rate and Outcome in Myocardial Infarction.
Susanne Karbach, Lukas Hobohm, Johannes Wild, Thomas Münzel, Tommaso Gori, Joanna Wegner, Kerstin Steinbrink, Philip Wenzel, Karsten Keller. J Am Heart Assoc 2020
12
11

Identification of common transcriptional regulatory elements in interleukin-17 target genes.
Fang Shen, Zihua Hu, Jaya Goswami, Sarah L Gaffen. J Biol Chem 2006
225
11

Effects of Interleukin 17A Inhibition on Myocardial Deformation and Vascular Function in Psoriasis.
George Makavos, Ignatios Ikonomidis, Ioanna Andreadou, Maria Varoudi, Irini Kapniari, Eleni Loukeri, Kostas Theodoropoulos, George Pavlidis, Helen Triantafyllidi, John Thymis,[...]. Can J Cardiol 2020
31
11

Anti-IL-17 antibody improves hepatic steatosis by suppressing interleukin-17-related fatty acid synthesis and metabolism.
Weidong Shi, Qiang Zhu, Jian Gu, Xiaoshan Liu, Ling Lu, Xiaofeng Qian, Jian Shen, Feng Zhang, Guoqiang Li. Clin Dev Immunol 2013
16
11

Structural basis of receptor sharing by interleukin 17 cytokines.
Lauren K Ely, Suzanne Fischer, K Christopher Garcia. Nat Immunol 2009
141
11

Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway.
Matthew J Lindemann, Zihua Hu, Marta Benczik, Kathleen D Liu, Sarah L Gaffen. J Biol Chem 2008
31
11

Fatty liver: a novel component of the metabolic syndrome.
Anna Kotronen, Hannele Yki-Järvinen. Arterioscler Thromb Vasc Biol 2008
596
11

IL-17C/IL-17RE: Emergence of a Unique Axis in TH17 Biology.
Jasper F Nies, Ulf Panzer. Front Immunol 2020
23
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.